278 related articles for article (PubMed ID: 21960098)
1. Glycoprotein production in moss bioreactors.
Decker EL; Reski R
Plant Cell Rep; 2012 Mar; 31(3):453-60. PubMed ID: 21960098
[TBL] [Abstract][Full Text] [Related]
2. Current achievements in the production of complex biopharmaceuticals with moss bioreactors.
Decker EL; Reski R
Bioprocess Biosyst Eng; 2008 Jan; 31(1):3-9. PubMed ID: 17701058
[TBL] [Abstract][Full Text] [Related]
3. Gene Targeting for Precision Glyco-Engineering: Production of Biopharmaceuticals Devoid of Plant-Typical Glycosylation in Moss Bioreactors.
Decker EL; Wiedemann G; Reski R
Methods Mol Biol; 2015; 1321():213-24. PubMed ID: 26082225
[TBL] [Abstract][Full Text] [Related]
4. The moss bioreactor.
Decker EL; Reski R
Curr Opin Plant Biol; 2004 Apr; 7(2):166-70. PubMed ID: 15003217
[TBL] [Abstract][Full Text] [Related]
5. Moss bioreactors producing improved biopharmaceuticals.
Decker EL; Reski R
Curr Opin Biotechnol; 2007 Oct; 18(5):393-8. PubMed ID: 17869503
[TBL] [Abstract][Full Text] [Related]
6. Glyco-engineering for biopharmaceutical production in moss bioreactors.
Decker EL; Parsons J; Reski R
Front Plant Sci; 2014; 5():346. PubMed ID: 25071817
[TBL] [Abstract][Full Text] [Related]
7. Recombinant glycoprotein production in human cell lines.
Swiech K; de Freitas MC; Covas DT; Picanço-Castro V
Methods Mol Biol; 2015; 1258():223-40. PubMed ID: 25447867
[TBL] [Abstract][Full Text] [Related]
8. Moss-made pharmaceuticals: from bench to bedside.
Reski R; Parsons J; Decker EL
Plant Biotechnol J; 2015 Oct; 13(8):1191-8. PubMed ID: 26011014
[TBL] [Abstract][Full Text] [Related]
9. Plant biofarming: novel insights for peptide expression in heterologous systems.
Viana AA; Pelegrini PB; Grossi-de-Sá MF
Biopolymers; 2012; 98(4):416-27. PubMed ID: 23193604
[TBL] [Abstract][Full Text] [Related]
10. Developments in the production of mucosal antibodies in plants.
Vasilev N; Smales CM; Schillberg S; Fischer R; Schiermeyer A
Biotechnol Adv; 2016; 34(2):77-87. PubMed ID: 26626615
[TBL] [Abstract][Full Text] [Related]
11. Antibody glycoengineering strategies in mammalian cells.
Wang Q; Chung CY; Chough S; Betenbaugh MJ
Biotechnol Bioeng; 2018 Jun; 115(6):1378-1393. PubMed ID: 29457629
[TBL] [Abstract][Full Text] [Related]
12. Production of therapeutic glycoproteins in glycoengineered plant: old farm for new crops.
Kao MR; Karmarkar Saldivar R; Hsieh YSY
Curr Opin Biotechnol; 2024 Jun; 87():103145. PubMed ID: 38781701
[TBL] [Abstract][Full Text] [Related]
13. Use of endogenous signal sequences for transient production and efficient secretion by moss (Physcomitrella patens) cells.
Schaaf A; Tintelnot S; Baur A; Reski R; Gorr G; Decker EL
BMC Biotechnol; 2005 Nov; 5():30. PubMed ID: 16271156
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Production of MFHR1, A Novel Synthetic Multitarget Complement Inhibitor, in Moss Bioreactors.
Top O; Parsons J; Bohlender LL; Michelfelder S; Kopp P; Busch-Steenberg C; Hoernstein SNW; Zipfel PF; Häffner K; Reski R; Decker EL
Front Plant Sci; 2019; 10():260. PubMed ID: 30949184
[TBL] [Abstract][Full Text] [Related]
15. Towards molecular farming in the future: moving from diagnostic protein and antibody production in microbes to plants.
Fischer R; Drossard J; Commandeur U; Schillberg S; Emans N
Biotechnol Appl Biochem; 1999 Oct; 30(2):101-8. PubMed ID: 10512787
[TBL] [Abstract][Full Text] [Related]
16. Production of biologically active recombinant human factor H in Physcomitrella.
Büttner-Mainik A; Parsons J; Jérôme H; Hartmann A; Lamer S; Schaaf A; Schlosser A; Zipfel PF; Reski R; Decker EL
Plant Biotechnol J; 2011 Apr; 9(3):373-83. PubMed ID: 20723134
[TBL] [Abstract][Full Text] [Related]
17. High-level expression of secreted complex glycosylated recombinant human erythropoietin in the Physcomitrella Delta-fuc-t Delta-xyl-t mutant.
Weise A; Altmann F; Rodriguez-Franco M; Sjoberg ER; Bäumer W; Launhardt H; Kietzmann M; Gorr G
Plant Biotechnol J; 2007 May; 5(3):389-401. PubMed ID: 17359496
[TBL] [Abstract][Full Text] [Related]
18. Unexpected Arabinosylation after Humanization of Plant Protein
Bohlender LL; Parsons J; Hoernstein SNW; Bangert N; Rodríguez-Jahnke F; Reski R; Decker EL
Front Bioeng Biotechnol; 2022; 10():838365. PubMed ID: 35252146
[TBL] [Abstract][Full Text] [Related]
19. Glyco-engineering of moss lacking plant-specific sugar residues.
Huether CM; Lienhart O; Baur A; Stemmer C; Gorr G; Reski R; Decker EL
Plant Biol (Stuttg); 2005 May; 7(3):292-9. PubMed ID: 15912449
[TBL] [Abstract][Full Text] [Related]
20. Plant glycoengineering for designing next-generation vaccines and therapeutic proteins.
Strasser R
Biotechnol Adv; 2023 Oct; 67():108197. PubMed ID: 37315875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
